Form 4: Verrica Pharmaceuticals Executive Buys Shares
Insider Transaction (Form 4)
Noah L. Rosenberg, CMO of Verrica Pharmaceuticals Inc., purchased 6,230 shares of common stock on August 17, 2026.
Summary
- Open-market purchase: acquired 4,200 Common Stock at $4.91 ($20,622) on August 17, 2026; holds 6,557 after (Direct).
- Open-market purchase: acquired 2,030 Common Stock at $4.92 ($9,988) on August 18, 2026; holds 8,587 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $30,610, committing personal capital to the stock.
Insider Transactions
Noah L. Rosenberg — Officer (CMO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Open-market purchase | Common Stock | 4,200 | $5 | $20.6K | 6,557 |
| 2026-08-18 | Open-market purchase | Common Stock | 2,030 | $5 | $10.0K | 8,587 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Open-market purchase (4,200 shares) |
| 2026-08-18 | Open-market purchase (2,030 shares) |
Keywords
insider transaction, Form 4, VRCA, Verrica Pharmaceuticals Inc., bullish, Noah L. Rosenberg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.